Found 207 with Last Name = 'coppo' and Initial = 'ft' 
Affinity DataIC50: 80nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 170nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 230nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 270nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 280nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 320nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 320nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 360nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 390nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 390nMAssay Description:Inhibition of human glycogen phosphorylase alpha in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 420nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 430nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 440nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 450nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 470nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 520nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 570nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 580nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 590nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 630nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 640nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 700nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 710nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 720nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 860nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 940nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 980nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in absence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 2.00E+3nMAssay Description:Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.90E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
